Abstract
Over the past couple of decades diuretics, methyldopa, and β-blockers have been the common drugs used as first-line regimen for treating hypertension [1–3]. Some large-scale long-term studies, however, have unmasked certain side effects of the diuretics and β-blockers, and they were seen not to be well tolerated in certain patients [4–9]. These findings have stimulated interest in the search for alternative regimens. Calcium antagonists have been found to be safe and effective in treating hypertensive crisis as well as resistant hypertension, although experience is still limited regarding its application as a firststep monotherapy regimen in hypertension [10–11]. With the availability of a long-acting preparation of nifedipine that is more convenient for users, the application of nifedipine as a first-line drug for treating mild to moderate hypertension may prove desirable and appealing [12–13].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
National Institute of Health (1973) Executive summary of the task force reports to the Hypertension Information and Education Advisory Committee. In: National high blood pressure education program, Bethesda, National Institute of Health, Washington, pp 1–20
Grimm RH, Luephker RV, Taylor H, Blackburn H (1982) Long term effects of a blood pressure survey on patient treatment in a community. Circulation 65: 946–950
Veterans Administration Cooperative Study Group on Antihypertensive Agents (1982) Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. I. Results of short term titration with emphasis on racial differences in response. JAMA 248: 1966–2003
Multiple Risk Factor Intervention Trial Research Group (1982) Multiple risk factor intervention trial: risk factor changes and mortality results. JAMA 248: 1465–1477
Medical Research Council Working Party (1981) Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Lancet ii: 539–544
McCarron DA (1984) Diuretic therapy for mild hypertension: the real cost of treatment. Am J Cardiol 53: 9A - 11A
Kaplan NM (1984) Therapy of mild hypertension: an overview. Am J Cardiol 53: 2A–8A
Opie LH (1984) Drugs and the heart four years on. Lancet i: 496–500
Koncaid-Smith P (1984) Beta-adrenergic receptor blocking drugs in hypertension. Special reference to their use as initial therapy. Am J Cardiol 53: 12A–15A
Bayly S, Dobbs RJ, Robinson BF (1982) Nifedipine in the treatment of hypertension: Report of a double-blind controlled trial. Clin Pharmacol 14: 509–512
Frishman W, Charlap S, Kimmel B et al. (1986) Twice-daily administration of oral Verapamil in the treatment of essential hypertension. Arch Intern Med 46: 561–565
Hornung Rs, Gould Ba, Jones RI, Sonecha TN, Raftery EB (1983) Nifedipine tablets for systemic hypertension: A study using continuous ambulatory intraarterial recording. Am J Cardiol 51: 1323–1327
Banzet O, Colin JN, Thibonnier M, Singlas E, Alexandre JM, Corvol P (1983) Acuteantihypertensive effect and pharmacokinetics of a tablet preparation of nifedipine. Europ J Clin Pharmacol 24: 145–150
Swinscow TVD (1976) The chi-square tests. Br Med J 2: 291–292
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Woo, K.S., Pun, C.O., Vallance-Owen, J. (1989). Nifedipine Retard as Monotherapy for Essential Hypertension: A Randomized Controlled Cross-over Study. In: Kelly, D.T. (eds) Adalat® in the Asian Pacific Region. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74911-7_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-74911-7_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-51388-9
Online ISBN: 978-3-642-74911-7
eBook Packages: Springer Book Archive